Alexandria Venture Healthcare News

This is selected healthcare news for Alexandria Venture, which is filed under Capital Firms. There are 591 news items for this page. Alexandria Venture is occasionally combined with Massachusetts Eye and Ear, GNS Healthcare and Sofinnova Partners in news items.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/14/2022 Another Philadelphia story: Capstan premieres with $165M investment | BioWorld
... including Pfizer Ventures, the Novartis Venture Fund, Leaps by Bayer, Bristol Myers Squibb Co., and Eli Lilly and Co., as well as private equity investors Orbimed, RA Capital, Vida Ventures, Polaris Partners, and Alexandria Venture Investments. Sparingvision closes $75M B round as it moves RP gene therapy to the clinic ...
BioWorld
9/14/2022 Novome secures $43.5m financing to advance GEMMs pipeline
... round. New investors including University of Minnesota, Navian Investments, Colorcon Ventures and Touchdown Ventures participated in the financing round, led by Tencent. In addition, existing investors DCVC Bio, 5AM Ventures, Alta Partners and Alexandria Venture Investments have also participated in the investment round. The biotechnology company intends to use the ...
ns-healthcare.com
9/14/2022 Capstan Therapeutics launches with $165M to deliver on in vivo cell engineering
... of Pennsylvania. Capstan's funding includes a recently closed $102 million series A financing led by Pfizer Ventures and joined by Leaps by Bayer, Eli Lilly and Company, Bristol Myers Squibb, Polaris Partners, Alexandria Venture Investments, and all existing investors, which follows a $63 million seed financing led by Novartis ...
labiotech.eu
9/14/2022 Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
... including Pfizer Ventures, Leaps by Bayer, Novartis Venture Fund, Eli Lilly and Company and Bristol Myers Squibb, as well as top life sciences investors including OrbiMed, RA Capital, Vida Ventures, Polaris Partners, and Alexandria Venture Investments - Laura Shawver, Ph.D., former CEO of Silverback Therapeutics and Synthorx, appointed as President and ...
post-gazette.com
9/14/2022 Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering
... including Pfizer Ventures, Leaps by Bayer, Novartis Venture Fund, Eli Lilly and Company and Bristol Myers Squibb, as well as top life sciences investors including OrbiMed, RA Capital, Vida Ventures, Polaris Partners, and Alexandria Venture Investments - Laura Shawver, Ph.D., former CEO of Silverback Therapeutics and Synthorx, appointed as President and ...
buffalonews.com
9/14/2022 Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering inyoregister.com
9/14/2022 - Capstan's foundation is built on research develo wapakdailynews.com
9/14/2022 Stock Market | FinancialContent Business Page financialcontent.com
9/14/2022 Capstan Therapeutics Launches with $165 Million to Deliver on the Clinical Promise of Precise In Vivo Cell Engineering winslowevanscrocker.com
9/13/2022 Novome Biotechnologies Raises $43.5 Million Series B Globe Newswire
9/13/2022 Novome gets $43.5M boost for its engineered microbiome therapies - MedCity News MedCity News
9/13/2022 Novome Biotechnologies Raises $43.5 Million Series B Financing to Advance its Pipeline of Therapeutically Engineered Microbes Yahoo News
9/9/2022 Autobahn raises funds for ABX-002 advancement to treat depression pharmaceutical-technology.com
9/8/2022 Autobahn Therapeutics Announces Successful Financing to Support Strategic Advancement of ABX-002 for Treatment Resistant Depression Business Wire
9/8/2022 Nohla Therapeutics raises $45M, gets new HQ as it moves novel leukemia treatment closer to market – GeekWire - Mekhato mekhato.com
8/23/2022 Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund PR Newswire
8/23/2022 Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund | Markets Insider Business Insider
8/23/2022 Medical Excellence Capital Announces $145 Million Final Close for Inaugural Venture Fund | Nachricht | finanzen.net finanzen.net
8/23/2022 Life Sciences Venture Investor MEC Raises $145 Million Fund The Wall Street Journal
8/17/2022 Flagship Pioneering's Senda Bio secures $123M for new ‘programmable medicines’ MedCity News
8/7/2022 How to Get Into a Corporate Accelerator - classes craigslist.org
6/23/2022 Go ask Alice: Eat me and don’t eat me signals at the heart of DEM Biopharma | BioWorld BioWorld
6/23/2022 DEM BioPharma Launches with $70 Million Financing Business Wire
6/8/2022 Pleno ‘Hypercoding’ Poised to Disrupt Clinical Testing sdbj.com
5/27/2022 Inspirna to Present Phase 1b RGX-202-01 Clinical Trial Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire